Atypical facial onset Guillain-Barré syndrome following first dose of COVISHIELD vaccine | Zendy

Rangenahalli Vasudev Aravinda | Zendy; Priyanka Tater | Zendy; Harsha Huliyappa | Zendy; Christy Joseph Manual | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Atypical facial onset Guillain-Barré syndrome following first dose of COVISHIELD vaccine

Author(s) -

Rangenahalli Vasudev Aravinda,

Priyanka Tater,

Harsha Huliyappa,

Christy Joseph Manual

Publication year - 2021

Publication title -

romanian journal of neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.111

H-Index - 4

eISSN - 2069-6094

pISSN - 1843-8148

DOI - 10.37897/rjn.2021.3.19

Subject(s) - guillain barre syndrome , medicine , covid-19 , pandemic , pediatrics , immunization , respiratory distress , acute respiratory distress , intensive care medicine , immunology , virology , surgery , disease , antibody , lung , outbreak , infectious disease (medical specialty)

In the midst of the global pandemic of COVID-19 and its significant morbidity and mortality reported across the world due to severe acute respiratory distress syndrome (SARS), it has always been posing a new set of complications each passing day. As we are still in the process of understanding about the complications related to COVID-19, we are encountered with complications related to immunization for COVID-19. We are reporting a case of facial onset Guillain-Barré syndrome (GBS) in the patient who received first dose of COVISHIELD vaccine a couple of weeks prior to the onset of his illness.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research